• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

他莫昔芬治疗术后绝经后乳腺癌患者时替代疗法的应用。

Use of alternative therapy in postmenopausal breast cancer patients treated with tamoxifen after surgery.

作者信息

Yap Karen P L, McCready David R, Fyles Anthony, Manchul Lee, Trudeau Maureen, Narod Steven

机构信息

Department of Surgical Oncology, Princess Margaret Hospital, 610 University Ave., Toronto, Ontario M5G 2M9, Canada.

出版信息

Breast J. 2004 Nov-Dec;10(6):481-6. doi: 10.1111/j.1075-122X.2004.21497.x.

DOI:10.1111/j.1075-122X.2004.21497.x
PMID:15569202
Abstract

The goal of this study was to determine the frequency of alternative therapy use in postmenopausal women with early stage breast cancer who were enrolled in a randomized clinical trial designed to determine the value of breast irradiation after treatment with breast-conserving surgery and tamoxifen. A questionnaire was given to 300 patients, ages 52 to 90 years, after completion of radiation therapy (if any). Of the 290 respondents, 78 (27%) had used some form of alternative therapy. Of these, 60.3% started after the diagnosis of breast cancer. Users of alternative therapies were significantly younger than nonusers (67.0 +/- 8.4 years versus 70.0 +/- 8.7 years, p = 0.009) and they used a median of one type of therapy per person (range 1-13). Users of alternative therapies were more likely to have experienced symptoms (stiffness, pain, numbness, or swelling) in the ipsilateral shoulder or arm after treatment of their breast cancers compared to nonusers (odds ratio [OR] = 2.0, p = 0.02). This relationship between alternative therapy use and symptoms was strongest in the group who started alternative therapies after breast cancer diagnosis (OR = 2.1, p = 0.05). On multivariate analysis, younger age and radiotherapy treatment were related to alternative therapy use. In conclusion, 27% of patients with early stage breast cancer used alternative therapy. Users were more likely to be younger and to experience shoulder or arm symptoms after breast-conserving surgery with radiation.

摘要

本研究的目的是确定参加一项随机临床试验的绝经后早期乳腺癌女性使用替代疗法的频率,该试验旨在确定保乳手术和他莫昔芬治疗后进行乳房照射的价值。在完成放射治疗(如有)后,向300名年龄在52至90岁之间的患者发放了问卷。在290名受访者中,78人(27%)使用了某种形式的替代疗法。其中,60.3%在乳腺癌诊断后开始使用。替代疗法使用者的年龄显著低于非使用者(67.0±8.4岁对70.0±8.7岁,p = 0.009),且每人使用的疗法中位数为一种(范围为1 - 13种)。与非使用者相比,替代疗法使用者在乳腺癌治疗后更有可能在同侧肩部或手臂出现症状(僵硬、疼痛、麻木或肿胀)(比值比[OR]=2.0,p = 0.02)。在乳腺癌诊断后开始使用替代疗法的人群中,替代疗法使用与症状之间的这种关系最为强烈(OR = 2.1,p = 0.05)。多因素分析显示,年龄较小和接受放射治疗与使用替代疗法有关。总之,27%的早期乳腺癌患者使用了替代疗法。使用者更有可能年龄较小,并且在保乳手术加放疗后出现肩部或手臂症状。

相似文献

1
Use of alternative therapy in postmenopausal breast cancer patients treated with tamoxifen after surgery.他莫昔芬治疗术后绝经后乳腺癌患者时替代疗法的应用。
Breast J. 2004 Nov-Dec;10(6):481-6. doi: 10.1111/j.1075-122X.2004.21497.x.
2
Radiation therapy plus tamoxifen versus tamoxifen alone after breast-conserving surgery in postmenopausal women with stage I breast cancer: a decision analysis.绝经后 I 期乳腺癌患者保乳手术后放疗加他莫昔芬与单纯他莫昔芬治疗的决策分析
J Clin Oncol. 2003 Jun 15;21(12):2260-7. doi: 10.1200/JCO.2003.07.072.
3
Improving local control with breast-conserving therapy: a 27-year single-institution experience.保乳治疗改善局部控制:一项27年的单机构经验。
Cancer. 2005 Jul 1;104(1):20-9. doi: 10.1002/cncr.21121.
4
Neoadjuvant treatment of postmenopausal breast cancer with anastrozole, tamoxifen, or both in combination: the Immediate Preoperative Anastrozole, Tamoxifen, or Combined with Tamoxifen (IMPACT) multicenter double-blind randomized trial.阿那曲唑、他莫昔芬或两者联合用于绝经后乳腺癌的新辅助治疗:术前即刻阿那曲唑、他莫昔芬或联合他莫昔芬(IMPACT)多中心双盲随机试验。
J Clin Oncol. 2005 Aug 1;23(22):5108-16. doi: 10.1200/JCO.2005.04.005. Epub 2005 Jul 5.
5
Low locoregional recurrence rate among node-negative breast cancer patients with tumors 5 cm or larger treated by mastectomy, with or without adjuvant systemic therapy and without radiotherapy: results from five national surgical adjuvant breast and bowel project randomized clinical trials.对肿瘤大小为5厘米或更大的无淋巴结转移乳腺癌患者行乳房切除术治疗,无论是否接受辅助全身治疗且未接受放疗,其局部区域复发率较低:五项国家外科辅助乳腺和肠道项目随机临床试验的结果
J Clin Oncol. 2006 Aug 20;24(24):3927-32. doi: 10.1200/JCO.2006.06.9054.
6
Effect of adjuvant systemic treatment on cosmetic outcome and late normal-tissue reactions after breast conservation.辅助全身治疗对保乳术后美容效果及晚期正常组织反应的影响。
Acta Oncol. 2007;46(4):525-33. doi: 10.1080/02841860701291698.
7
The use of radiation therapy after breast-conserving surgery in hormonally treated breast cancer patients is dependent on patient age, geographic region, and surgeon specialty.激素治疗的乳腺癌患者保乳手术后放疗的应用取决于患者年龄、地理区域和外科医生专业。
Am J Surg. 2008 Jun;195(6):793-8. doi: 10.1016/j.amjsurg.2007.07.027. Epub 2008 Apr 16.
8
Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ.国家综合癌症网络中随机临床试验结果对原位导管癌乳房手术后他莫昔芬使用情况的影响。
J Clin Oncol. 2007 Aug 1;25(22):3251-8. doi: 10.1200/JCO.2006.10.2699. Epub 2007 Jun 18.
9
Arm and shoulder morbidity in breast cancer patients after breast-conserving therapy versus mastectomy.保乳治疗与乳房切除术后乳腺癌患者的手臂和肩部并发症
Acta Oncol. 2008;47(5):835-42. doi: 10.1080/02841860801961257.
10
Are all aromatase inhibitors the same? A review of controlled clinical trials in breast cancer.所有芳香化酶抑制剂都一样吗?乳腺癌对照临床试验综述。
Clin Ther. 2005 Nov;27(11):1671-84. doi: 10.1016/j.clinthera.2005.11.013.

引用本文的文献

1
Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis.癌症患者中使用草药的患病率:一项系统评价和荟萃分析。
Evid Based Complement Alternat Med. 2021 May 17;2021:9963038. doi: 10.1155/2021/9963038. eCollection 2021.
2
Reasons to Use and Disclose Use of Complementary Medicine Use - An Insight from Cancer Patients.使用和披露补充医学疗法的原因——来自癌症患者的见解。
Cancer Clin Oncol. 2013 Nov;2(2):81-92. doi: 10.5539/cco.v2n2p81. Epub 2013 Oct 7.
3
Practices, attitudes, and beliefs associated with complementary and alternative medicine (CAM) use among cancer patients.
癌症患者对补充和替代医学(CAM)的使用相关的实践、态度和信念。
Integr Cancer Ther. 2012 Sep;11(3):232-42. doi: 10.1177/1534735411433832. Epub 2012 Feb 7.
4
Use of Chinese medicine by cancer patients: a review of surveys.癌症患者对中医药的使用:综述调查
Chin Med. 2011 Jun 9;6:22. doi: 10.1186/1749-8546-6-22.
5
Complementary and alternative medicine use and assessment of quality of life in Korean breast cancer patients: a descriptive study.韩国乳腺癌患者的补充和替代医学使用及生活质量评估:一项描述性研究。
Support Care Cancer. 2012 Mar;20(3):461-73. doi: 10.1007/s00520-011-1094-z. Epub 2011 Jan 28.
6
Complementary and alternative medicine use among cancer survivors: a population-based study.癌症幸存者中补充和替代医学的使用:一项基于人群的研究。
J Cancer Surviv. 2011 Mar;5(1):8-17. doi: 10.1007/s11764-010-0153-7. Epub 2010 Oct 6.